- Report
- July 2022
- 96 Pages
Asia Pacific
From €1326EUR$1,500USD£1,144GBP
- Report
- November 2021
- 131 Pages
Global
From €13258EUR$14,995USD£11,437GBP
- Drug Pipelines
- November 2020
- 342 Pages
Global
From €1768EUR$2,000USD£1,525GBP
- Report
- March 2023
- 100 Pages
Global
From €2210EUR$2,500USD£1,907GBP
- Report
- March 2023
- 40 Pages
China
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
United States
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
South Korea
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
Saudi Arabia
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
Russia
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
India
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
Germany
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
France
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
Poland
From €1326EUR$1,500USD£1,144GBP
From €1326EUR$1,500USD£1,144GBP
- Report
- March 2023
- 40 Pages
United Kingdom
From €1326EUR$1,500USD£1,144GBP
- Report
- July 2024
- 99 Pages
Global
From €3500EUR$4,240USD£3,125GBP
- Report
- March 2022
- 77 Pages
Global
From €3500EUR$4,240USD£3,125GBP
- Report
- September 2022
- 269 Pages
Global
From €1768EUR$2,000USD£1,525GBP
- Report
- January 2025
- 132 Pages
Global
From €840EUR$950USD£725GBP
- Report
- December 2023
- 132 Pages
Global
From €840EUR$950USD£725GBP

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists.
Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more